
September 11, 2023
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector stays positive
September 11, 2023
RegMed Investors’ (RMi) pre-open: The September Effect
September 8, 2023
RegMed Investors (RMi) Closing Bell: a barely positive sector rebound, better than staring into a share pricing abyss
September 8, 2023
RegMed Investors’ (RMi) pre-open: reverse the sector’s downer curse
September 7, 2023
RegMed Investors (RMi) Closing Bell: Gaze into the abyss, the abyss gazes also into you
September 7, 2023
RegMed Investors’ (RMi) pre-open: Hope is not a good investment strategy
September 6, 2023
RegMed Investors (RMi) Closing Bell: a lack of sector friction flips with positive force
September 6, 2023
RegMed Investors’ (RMi) pre-open: risk gets riskier
September 5, 2023
RegMed Investors (RMi) Closing Bell: deep dive to the downside
September 5, 2023
RegMed Investors’ (RMi) pre-open: a challenging September ahead?
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors